retatrutide side effects long-term UK Guide: Uses, Evidence, & Access Retatrutide – The New Weight

Retatrutide is a triple agonist (GLP-1/GIP/Glucagon) studied for weight loss and glucose control

Severe gastrointestinal reactions Saxenda is associated with gastrointestinal side effects including nausea, vomiting, and diarrhea, which can sometimes be severe

Fed Proc 1984

By targeting both GLP-1 and GIP receptors, Tirzepatide has the potential to more effectively address multiple aspects of metabolic syndrome than single-target therapies, making it a promising option for MASH treatment2

doi: 10.1016/j.cmet.2017.04.013 69 MoreiraGAzevedoFRibeiroLSantosAGuadagniniDGamaPet al

GLP-1 drugs have been around for more than a decade to help people manage type 2 diabetes, but the ones developed in recent yearsOzempic, Wegovy, Mounjaro, and Zepboundhave exploded in popularity after becoming the worst-kept celebrity weight-loss secret